查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
处方药市场规模及预测 2021-2031、全球及地区份额、趋势及成长机会分析报告涵盖：产品类型、药物类型、治疗领域、给药途径、配销通路及地理
市场调查报告书
商品编码
1780283

处方药市场规模及预测 2021-2031、全球及地区份额、趋势及成长机会分析报告涵盖：产品类型、药物类型、治疗领域、给药途径、配销通路及地理

Prescription Drugs Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type, Drug Type, Therapeutic Area, Route Of Administration, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 329 Pages | 订单完成后即时交付

价格

根据我们关于「2031 年处方药市场预测 - 全球分析 - 按产品类型、药物类型、给药途径、治疗领域和配销通路」的新研究，预计市场规模将从 2024 年的 14,407.9 亿美元增长到 2031 年的 23,501.2 亿美元；预计 2025 年至 2031 年的复合年增长率为 203%。处方药市场的成长归因于慢性病盛行率的不断上升以及创新药物和特殊药物的开发和应用。

处方药是指依法需要持有执业医疗专业人员处方才能购买的药物。由于处方药可能对人体产生重大影响、需要安全监测或有滥用风险，因此受到监管。

北美处方药市场分为美国、加拿大和墨西哥。北美很可能占据全球市场的很大份额。主要驱动因素之一是该地区的人口老化。随着婴儿潮世代逐渐老去，糖尿病、心血管疾病和癌症等慢性病的发生率也随之上升，刺激了处方药的需求。

药物研究和生物技术的进步也发挥了关键作用。包括生物製剂和个人化医疗在内的药物开发创新拓展了治疗选择，提高了疗效和安全性。针对先前无法治癒的疾病的新型疗法的引入进一步推动了市场成长。

另一个主要因素是北美强大的医疗基础设施，这得益于对医疗机构、保险覆盖和药品分销网络的大量投资。医疗服务的普及以及病患疾病管理意识的提高，增加了处方药的消费。此外，美国食品药物管理局 (FDA) 等机构的监管支持加快了创新药物的审批流程，使其能够更快进入市场。此外，旨在扩大医疗保险覆盖范围的政府倡议，例如美国的《平价医疗法案》，也增加了更广泛人群获得处方药的机会。

此外，生活方式相关疾病的增加以及精神健康障碍的盛行率上升，也导致了对治疗药物的持续需求。新冠疫情也凸显了药物介入的重要性，加速了对药物研发和分销的投资。

在北美，美国占据了处方药市场的很大份额。癌症、心臟病和糖尿病等慢性疾病导致处方药需求不断增加。心臟病仍然是美国最大的死亡原因，每年有近一百万美国人死于心血管疾病 (CVD)。根据美国心臟协会统计，近一半的美国成年人患有某种类型的心血管疾病 (CVD)，预计到 2035 年，患有心臟衰竭的成年人数量将会增加。预计到 2035 年，将有超过 1.3 亿成年人（占美国人口的 45.1%）患有某种形式的心血管疾病。心血管疾病病例的激增导致需要长期药物管理的患者数量增加，包括他汀类药物、β 受体阻断剂、抗凝血剂和抗高血压药物。

根据美国癌症协会统计，2022 年美国新增癌症病例约 190 万例，癌症导致约 61 万人死亡。随着癌症病例的增加，对创新治疗方案的需求也上升。治疗性疫苗为传统疗法提供了一个有希望的替代方案。 2010 年获得 FDA 批准的 Provenge (sipuleucel-T) 是第一个获得批准并成为癌症治疗处方药的治疗性癌症疫苗。此外，肿瘤学、免疫学和基因疗法的进步正在扩大各种癌症和自体免疫疾病的治疗选择。儘管取得了这些进步，处方药支出仍在持续上升。根据美国卫生系统药剂师协会统计，2024 年美国人在处方药上的支出为 8,059 亿美元，比前一年增加 10.2%。这一增长归因于对这些药物的需求增加以及新的昂贵治疗方法的推出。此外，79%的美国人认为处方药价格“不合理”，而70%的人认为降低这些成本是他们的首要医疗保健重点。根据兰德公司的数据，美国处方药价格平均比其他32个经济合作暨发展组织（OECD）成员国高出2.56倍，品牌药价格更是高出3.44倍。为了解决这些成本问题，旨在协商联邦医疗保险（Medicare）药品价格的《通货膨胀削减法案》（IRA）应运而生。 2024年，美国政府最终确定了《通货膨胀削减法案2022》中首批十种药品的价格，这是一个重要的里程碑。经过数月与药品製造商的谈判，Stelara和Jardiance等药品的价格已下调38%至79%。预计到2026年，这些变化将为纳税人节省60亿美元，并为患者节省15亿美元。

在支出持续成长的同时，立法工作也在进行中，旨在让美国人更负担得起药物。 2025年5月，唐纳德·川普总统签署了一项行政命令，题为「向美国患者提供最惠国处方药定价」。川普表示，该命令旨在使美国人和纳税人支付的处方药价格与同类国家的价格保持一致。预计该措施将使药价至少降低50%，并被认为是川普2020年最惠国模式的更激进版本。

个人化和精准医疗的成长为未来提供市场机会

个人化医疗和精准医疗正经历技术进步的不断推进，人们对基因组学的理解日益加深，个人化治疗方法的应用也日益广泛。个人化医疗是指根据个人基因、环境和生活方式因素量身订做医疗保健，从而实现更有效、更有针对性的治疗。曲妥珠单抗（赫赛汀）等针对 HER2 阳性乳癌的标靶癌症疗法的开发，体现了基因分析如何识别最能从特定治疗中获益的患者，从而提高疗效并减少不良反应。伴随诊断的日益普及有望将基因检测整合到常规临床实践中，从而提高药物的疗效和安全性。

人工智慧 (AI) 和巨量资料分析等技术进步正在加速个人化医疗的探索。人工智慧驱动的演算法能够分析大量资料集，预测个体对药物的反应，识别新的治疗标靶，并简化药物开发流程。例如，Tempus 等公司正在利用人工智慧根据患者的基因图谱来客製化癌症治疗方案，提供更精准、更有效的干预措施。因此，技术创新以及更有效、更安全、以患者为中心的疗法在临床上的广泛应用，将改变全球医疗服务的提供方式和疗效，预计将在未来几年推动市场成长。

美国食品药物管理局、国家癌症研究所、欧洲药品管理局、中央药品标准控制组织和我们的世界资料是编写处方药市场报告时参考的主要和次要来源。

目录

第一章：简介

第二章：执行摘要

  • 分析师市场展望

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：
  • 假设和局限性

第四章：处方药市场格局

  • 概述
  • PEST分析

第五章：处方药市场－关键市场动态

  • 处方药市场－关键市场动态
  • 市场驱动因素：
    • 慢性疾病盛行率不断上升
    • 创新药物和特殊药物的开发和应用
  • 市场限制
    • 药价高昂，且难以负担
  • 市场机会
    • 市场参与者的策略性倡议
  • 未来趋势
    • 个人化和精准医疗的发展
  • 驱动因素和限制因素的影响：

第六章：处方药市场－全球市场分析

  • 处方药市场收入（2021-2031）
  • 处方药市场预测分析

第七章：处方药市场分析－依产品类型

  • 品牌
  • 泛型

第 8 章：处方药市场分析 - 依药品类型

  • 小分子
  • 生物製剂和生物相似药

第九章：处方药市场分析－依治疗领域

  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 代谢性疾病
  • 呼吸系统疾病
  • 免疫学
  • 其他的

第 10 章：处方药市场分析 - 按给药途径

  • 口服
  • 注射剂
  • 外用
  • 其他的

第 11 章：处方药市场分析 - 按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

第 12 章：处方药市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 13 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 14 章：产业格局

  • 概述
  • 处方药市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十五章：公司简介

  • Johnson & Johnson
  • Pfizer Inc
  • Merck & Co Inc
  • Eli Lilly and Co
  • ESTEVE
  • AstraZeneca Plc
  • Sanofi SA
  • GSK Plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • AbbVie Inc
  • Teva Pharmaceutical Industries Ltd

第 16 章：附录

Product Code: TIPRE00040966

According to our new research study on "Prescription Drugs Market Forecast to 2031 -Global Analysis - by Product Type, Drug Type, Route Of Administration, Therapeutic Area, And Distribution Channel," the market is anticipated to grow from US$ 1,440.79 billion in 2024 and is projected to reach US$ 2,350.12 billion by 2031; it is expected to register a CAGR of 7.3% from 2025 to 2031. The prescription drugs market growth is attributed to the increasing prevalence of chronic disorders and development and adoption of innovative and specialty drugs.

Prescription drugs are medications that legally require a medical prescription from a licensed healthcare professional. They are regulated because they can have significant effects on the body, require monitoring for safety, or have potential for misuse.

The prescription drugs market in North America is segmented into the US, Canada, and Mexico. North America is likely to capture a significant share of the global market. One of the primary drivers is the region's aging population. As the baby boomer generation grows older, the prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer has increased, thereby boosting the demand for prescription medications.

Advancements in pharmaceutical research and biotechnology have also played a critical role. Innovations in drug development, including biologics and personalized medicine, have expanded treatment options, enhancing efficacy and safety. The introduction of novel therapies for previously untreatable conditions has further propelled market growth.

Another major contributor is the strong healthcare infrastructure in North America, supported by substantial investments in healthcare facilities, insurance coverage, and pharmaceutical distribution networks. The widespread availability of healthcare services and better patient awareness about disease management have increased prescription drug consumption. Additionally, regulatory support from agencies such as the US Food and Drug Administration (FDA) facilitates quicker approval processes for innovative drugs, enabling faster market entry. Furthermore, government initiatives aimed at expanding healthcare coverage, such as the Affordable Care Act in the US, have increased access to prescription drugs for a broader population.

Also, the rise in lifestyle-related diseases and increased prevalence of mental health disorders have created a sustained demand for therapeutic drugs. The COVID-19 pandemic also emphasized the importance of pharmaceutical interventions, accelerating investments in drug development and distribution.

In North America, the US holds a significant share of the prescription drugs market. Chronic conditions such as cancer, heart disease, and diabetes are contributing to the rising demand for prescription medications. Heart disease remains the leading cause of death in the US, with nearly one million Americans annually succumbing to cardiovascular disease (CVD). According to the American Heart Association, nearly half of all adults in the US have some type of CVD, and it is estimated that the number of adults suffering from heart failure is projected to increase by 2035. Over 130 million adults, i.e., 45.1% of the US population, are expected to report some form of CVD by 2035. This surge in CVD cases leads to a higher number of patients requiring long-term medication management, including statins, beta-blockers, anticoagulants, and antihypertensive drugs.

According to the American Cancer Society, in 2022, ~1.9 million new cases of cancer were diagnosed in the country, and it caused ~0.61 million deaths. With the increasing cases of cancer, the demand for innovative treatment options is rising. Therapeutic vaccines offer promising alternatives to traditional therapies. Provenge (sipuleucel-T), approved by the FDA in 2010, is the first therapeutic cancer vaccine to receive approval and prescribed medication for cancer treatment. Additionally, advancements in oncology, immunology, and gene therapies are expanding treatment options for various cancers and autoimmune diseases. Despite these advancements, prescription drug spending continues to rise. According to the American Society of Health-System Pharmacists, in 2024, Americans spent US$ 805.9 billion on prescription drugs, a 10.2% increase from the previous year. This increase is attributed to higher demand for these medications and the introduction of new, expensive treatments. Additionally, 79% of Americans believe that prescription drug prices are "unreasonable," while 70% consider reducing these costs to be their top healthcare priority. According to the Rand Corporation, on average, prescription drug prices in the US are 2.56 times higher than those in 32 other Organization for Economic Co-operation and Development (OECD) countries, with brand-name medications costing 3.44 times more. To address these costs, the Inflation Reduction Act (IRA), which aims to negotiate drug prices for Medicare, was introduced. In 2024, the US government finalized prices for the first ten drugs under the IRA 2022, marking a significant milestone. After months of negotiations with drug manufacturers, prices for medications such as Stelara and Jardiance have reduced by 38% to 79%. These changes are anticipated to save taxpayers US$6 billion by 2026 and provide US$1.5 billion in savings for patients.

While spending continues to rise, legislative efforts are underway to make medications more affordable for Americans. In May 2025, President Donald Trump signed an executive order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients." Trump stated that the order aims to align the prices Americans and taxpayers pay for prescription drugs with those paid in comparable countries. The measure is expected to cut drug prices by at least 50% and is characterized as a more aggressive version of Trump's 2020 Most Favored Nation model.

Growth of Personalized and Precision Medicine to Provide Market Opportunities in Future

Personalized and precision medicine is experiencing growing technological advancements, increasing understanding of genomics, and rising adoption of personalized therapeutic approaches. Personalized medicine involves customizing healthcare based on individual genetic, environmental, and lifestyle factors, allowing for more effective and targeted treatments. The development of targeted cancer therapies such as trastuzumab (Herceptin) for HER2-positive breast cancer exemplifies how genetic profiling can identify patients who will benefit most from specific treatments, improving efficacy and reducing adverse effects. The increasing adoption of companion diagnostics is expected to integrate genetic testing into routine clinical practice, enhancing drug efficacy and safety.

Technological advancements such as artificial intelligence (AI) and big data analytics are accelerating discoveries in personalized medicine. AI-driven algorithms analyze vast datasets to predict individual responses to drugs, identify new therapeutic targets, and streamline drug development processes. For instance, companies such as Tempus are harnessing AI to tailor cancer treatments based on patients' genetic profiles, offering more precise and effective interventions. Therefore, technological innovations and increasing clinical adoption of more effective, safer, and patient-centric therapies, transforming healthcare delivery and outcomes globally, are expected to contribute to the market growth in coming years.

The US Food and Drug Administration, National Cancer Institute, European Medicines Agency, Central Drugs Standard Control Organization, and Our World in data are among the primary and secondary sources referred to while preparing the prescription drugs market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Prescription Drugs Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Prescription Drugs Market - Key Market Dynamics

  • 5.1 Prescription Drugs Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Increasing Prevalence of Chronic Disorders
    • 5.2.2 Development and Adoption of Innovative and Specialty Drugs
  • 5.3 Market Restraints
    • 5.3.1 High Drug Prices and Affordability Issues
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Growth of Personalized and Precision Medicine
  • 5.6 Impact of Drivers and Restraints:

6. Prescription Drugs Market - Global Market Analysis

  • 6.1 Prescription Drugs Market Revenue (US$ Billion), 2021-2031
  • 6.2 Prescription Drugs Market Forecast Analysis

7. Prescription Drugs Market Analysis - by Product Type

  • 7.1 Branded
    • 7.1.1 Overview
    • 7.1.2 Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 7.2 Generics
    • 7.2.1 Overview
    • 7.2.2 Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

8. Prescription Drugs Market Analysis - by Drug Type

  • 8.1 Small Molecule
    • 8.1.1 Overview
    • 8.1.2 Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.2 Biologics and Biosimilar
    • 8.2.1 Overview
    • 8.2.2 Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

9. Prescription Drugs Market Analysis - by Therapeutic Area

  • 9.1 Oncology
    • 9.1.1 Overview
    • 9.1.2 Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.2 Cardiovascular Diseases
    • 9.2.1 Overview
    • 9.2.2 Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.3 Neurological Diseases
    • 9.3.1 Overview
    • 9.3.2 Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.4 Metabolic Diseases
    • 9.4.1 Overview
    • 9.4.2 Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.5 Respiratory Diseases
    • 9.5.1 Overview
    • 9.5.2 Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.6 Immunology
    • 9.6.1 Overview
    • 9.6.2 Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

10. Prescription Drugs Market Analysis - by Route Of Administration

  • 10.1 Oral
    • 10.1.1 Overview
    • 10.1.2 Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.2 Injectable
    • 10.2.1 Overview
    • 10.2.2 Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.3 Topical
    • 10.3.1 Overview
    • 10.3.2 Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

11. Prescription Drugs Market Analysis - by Distribution Channel

  • 11.1 Hospital Pharmacies
    • 11.1.1 Overview
    • 11.1.2 Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.2 Retail Pharmacies
    • 11.2.1 Overview
    • 11.2.2 Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.3 Online Pharmacies
    • 11.3.1 Overview
    • 11.3.2 Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

12. Prescription Drugs Market - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Prescription Drugs Market Overview
    • 12.1.2 North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.1.2.1 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.1.2.2 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.1.2.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.1.2.4 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.1.2.5 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.1.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.1.1 United States: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.1.2 United States: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.1.3 United States: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.1.4 United States: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.1.5 United States: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.1.3.2 Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.2.1 Canada: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.2.2 Canada: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.2.3 Canada: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.2.4 Canada: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.2.5 Canada: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.1.3.3 Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.3.1 Mexico: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.3.2 Mexico: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.3.3 Mexico: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.3.4 Mexico: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.3.5 Mexico: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.2 Europe
    • 12.2.1 Europe Prescription Drugs Market Overview
    • 12.2.2 Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.2.2.1 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.2.2.2 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.2.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.2.2.4 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.2.2.5 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.2.3.1 Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.1.1 Germany: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.1.2 Germany: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.1.3 Germany: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.1.4 Germany: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.1.5 Germany: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.2 United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.2.1 United Kingdom: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.2.2 United Kingdom: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.2.3 United Kingdom: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.2.4 United Kingdom: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.2.5 United Kingdom: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.3 France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.3.1 France: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.3.2 France: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.3.3 France: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.3.4 France: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.3.5 France: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.4 Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.4.1 Italy: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.4.2 Italy: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.4.3 Italy: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.4.4 Italy: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.4.5 Italy: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.5 Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.5.1 Spain: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.5.2 Spain: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.5.3 Spain: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.5.4 Spain: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.5.5 Spain: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.6 Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.6.1 Rest of Europe: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.6.2 Rest of Europe: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.6.3 Rest of Europe: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.6.4 Rest of Europe: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.6.5 Rest of Europe: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.3 Asia Pacific
    • 12.3.1 Asia Pacific Prescription Drugs Market Overview
    • 12.3.2 Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.3.2.1 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.3.2.2 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.3.2.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.3.2.4 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.3.2.5 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.3.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.3.3.1 China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.1.1 China: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.1.2 China: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.1.3 China: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.1.4 China: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.1.5 China: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.2 Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.2.1 Japan: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.2.2 Japan: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.2.3 Japan: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.2.4 Japan: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.2.5 Japan: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.3 India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.3.1 India: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.3.2 India: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.3.3 India: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.3.4 India: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.3.5 India: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.4 Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.4.1 Australia: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.4.2 Australia: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.4.3 Australia: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.4.4 Australia: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.4.5 Australia: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.5 South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.5.1 South Korea: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.5.2 South Korea: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.5.3 South Korea: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.5.4 South Korea: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.5.5 South Korea: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.6 Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.6.1 Rest of APAC: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.6.2 Rest of APAC: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.6.3 Rest of APAC: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.6.4 Rest of APAC: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.6.5 Rest of APAC: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.4 Middle East and Africa
    • 12.4.1 Middle East and Africa Prescription Drugs Market Overview
    • 12.4.2 Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.4.2.1 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.4.2.2 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.4.2.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.4.2.4 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.4.2.5 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.4.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.1 Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.1.1 Saudi Arabia: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.1.2 Saudi Arabia: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.1.3 Saudi Arabia: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.1.4 Saudi Arabia: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.1.5 Saudi Arabia: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.2 South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.2.1 South Africa: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.2.2 South Africa: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.2.3 South Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.2.4 South Africa: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.2.5 South Africa: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.3 United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.3.1 United Arab Emirates: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.3.2 United Arab Emirates: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.3.3 United Arab Emirates: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.3.4 United Arab Emirates: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.3.5 United Arab Emirates: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.4 Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.4.1 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.4.2 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.4.3 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.4.4 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.4.5 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.5 South and Central America
    • 12.5.1 South and Central America Prescription Drugs Market Overview
    • 12.5.2 South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.5.2.1 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.5.2.2 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.5.2.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.5.2.4 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.5.2.5 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.5.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.1 Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.1.1 Brazil: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.1.2 Brazil: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.1.3 Brazil: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.1.4 Brazil: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.1.5 Brazil: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.5.3.2 Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.2.1 Argentina: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.2.2 Argentina: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.2.3 Argentina: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.2.4 Argentina: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.2.5 Argentina: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.5.3.3 Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.3.1 Rest of South and Central America: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.3.2 Rest of South and Central America: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.3.3 Rest of South and Central America: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.3.4 Rest of South and Central America: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.3.5 Rest of South and Central America: Prescription Drugs Market Breakdown, by Distribution Channel

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning & Concentration

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Prescription Drugs Market
  • 14.3 Organic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Inorganic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Johnson & Johnson
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Pfizer Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Merck & Co Inc
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Eli Lilly and Co
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 ESTEVE
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 AstraZeneca Plc
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Sanofi SA
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 GSK Plc
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 F. Hoffmann-La Roche Ltd
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Novartis AG
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 AbbVie Inc
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Teva Pharmaceutical Industries Ltd
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms

List Of Tables

  • Table 1. Prescription Drugs Market Segmentation
  • Table 2. Key Brands Facing Patent Expirations
  • Table 3. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 4. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 5. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 6. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 7. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 8. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 9. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 10. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 11. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 12. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 13. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 14. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 15. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 16. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 17. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 18. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 19. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 20. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 21. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 22. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 23. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 24. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 25. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 26. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 27. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 28. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 29. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 30. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 31. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 32. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 33. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 34. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 35. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 36. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 37. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 38. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 39. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 40. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 41. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 42. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 43. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 44. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 45. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 46. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 47. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 48. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 49. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 50. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 51. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 52. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 53. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 54. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 55. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 56. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 57. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 58. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 59. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 60. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 61. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 62. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 63. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 64. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 65. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 66. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 67. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 68. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 69. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 70. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 71. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 72. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 73. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 74. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 75. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 76. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 77. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 78. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 79. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 80. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 81. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 82. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 83. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 84. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 85. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 86. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 87. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 88. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 89. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 90. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 91. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 92. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 93. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 94. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 95. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 96. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 97. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 98. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 99. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 100. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 101. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 102. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 103. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 104. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 105. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 106. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 107. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 108. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 109. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 110. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 111. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 112. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 113. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 114. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 115. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 116. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 117. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 118. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 119. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 120. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 121. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 122. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 123. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 124. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 125. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 126. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 127. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 128. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 129. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 130. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 131. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 132. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 133. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 134. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 135. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 136. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 137. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 138. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 139. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 140. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 141. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 142. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 143. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 144. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 145. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 146. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 147. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 148. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 149. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 150. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 151. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 152. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 153. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 154. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 155. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 156. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 157. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 158. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 159. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 160. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 161. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 162. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 163. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 164. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 165. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 166. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 167. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 168. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 169. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 170. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 171. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 172. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 173. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 174. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 175. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 176. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 177. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 178. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 179. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 180. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 181. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 182. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 183. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 184. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 185. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 186. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 187. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 188. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 189. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 190. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 191. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 192. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 193. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 194. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 195. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 196. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 197. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 198. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 199. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 200. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 201. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 202. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 203. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 204. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 205. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 206. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 207. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 208. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 209. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 210. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 211. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 212. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 213. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 214. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 215. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 216. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 217. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 218. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 219. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 220. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 221. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 222. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 223. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 224. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 225. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 226. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 227. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 228. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 229. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 230. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 231. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 232. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 233. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 234. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 235. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 236. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 237. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 238. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 239. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 240. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 241. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 242. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 243. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 244. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 245. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 246. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 247. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 248. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 249. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 250. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 251. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 252. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 253. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 254. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 255. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 256. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 257. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 258. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 259. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 260. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 261. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 262. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 263. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 264. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 265. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 266. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 267. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 268. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 269. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 270. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 271. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 272. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 273. Heat Map Analysis by Key Players
  • Table 274. Recent Organic Growth Strategies in the Prescription Drugs Market
  • Table 275. Recent Inorganic Growth Strategies in the Prescription Drugs Market
  • Table 276. Glossary of Terms, Medical Cables Market

List Of Figures

  • Figure 1. Prescription Drugs Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Prescription Drugs Market Revenue (US$ Billion), 2021-2031
  • Figure 5. Prescription Drugs Market Revenue (US$ Billion) Forecast Analysis, 2021-2031
  • Figure 6. Prescription Drugs Market Share (%) - by Product Type (2024 and 2031)
  • Figure 7. Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 8. Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 9. Prescription Drugs Market Share (%) - by Drug Type (2024 and 2031)
  • Figure 10. Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 11. Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 12. Prescription Drugs Market Share (%) - by Therapeutic Area (2024 and 2031)
  • Figure 13. Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 14. Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 15. Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 16. Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 17. Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 18. Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 19. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 20. Prescription Drugs Market Share (%) - by Route Of Administration (2024 and 2031)
  • Figure 21. Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 22. Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 23. Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 24. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 25. Prescription Drugs Market Share (%) - by Distribution Channel (2024 and 2031)
  • Figure 26. Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 27. Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 28. Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 29. North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 30. North America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 32. Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 33. Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 34. Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 35. Europe: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 36. Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 37. United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 38. France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 39. Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 40. Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 41. Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 42. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 43. Asia Pacific: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 44. China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 45. Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 46. India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 47. Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 48. South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 49. Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 50. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 51. Middle East and Africa: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 53. South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 54. United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 55. Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 56. South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 57. South and Central America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 58. Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 59. Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 60. Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 61. Company Positioning & Concentration
  • Figure 62. Growth Strategies in the Prescription Drugs Market